Additionally, serum HE4 levels in lung cancer patients at stages I–II were significantly higher than those in healthy controls (p < 0.001), suggesting an elevation of HE4 in the early stages of lung cancer. This evidence concerns the gene WFDC2 and lung carcinoma.